Medical abbreviations play a vital role in the work and research that goes on in a hospital. However, there can be a certain amount of confusion associated with their use. The authors conducted a survey among radiology doctors to assess their...
Medical abbreviations play a vital role in the work and research that goes on in a hospital. However, there can be a certain amount of confusion associated with their use. The authors conducted a survey among radiology doctors to assess their...
This study evaluates the efficacy of vascular surgery simulation training in learning surgical skills, improving readiness for clinical rotations or fourth-year sub-internships, and capturing early interest in surgical specialties.
This study evaluates the efficacy of vascular surgery simulation training in learning surgical skills, improving readiness for clinical rotations or fourth-year sub-internships, and capturing early interest in surgical specialties.
1Department of Vascular Surgery, Command Hospital (Southern Command), Pune, India; 2Military Hospital, Meerut, Uttar Pradesh, India; 3Department of Radiodiagnosis, Dr NY Tasgaonkar Medical College, Karjat, Maharashtra, India; 4Department of General Surgery, Armed Forces Medical College, Pune, India
Rohit Mehra, DrNB1; Vikram Patra, Mch...
Failure of an SBVCD is an independent predictor of vascular complications and a leading cause of morbidity. This collection of cases illustrates the failure of SBVCDs, including the associated challenges, management strategies, and outcomes.
Failure of an SBVCD is an independent predictor of vascular complications and a leading cause of morbidity. This collection of cases illustrates the failure of SBVCDs, including the associated challenges, management strategies, and outcomes.
The authors evaluate the technical feasibility, long-term patency rate, and clinical outcome in patients who presented with symptomatic acute portomesenteric thrombosis and were treated with mechanical thrombectomy and pharmacological...
The authors evaluate the technical feasibility, long-term patency rate, and clinical outcome in patients who presented with symptomatic acute portomesenteric thrombosis and were treated with mechanical thrombectomy and pharmacological...
Although the link between COVID-19 and ALI has been established, the particularities of the patients remain poorly described and their management not codified because of its emergent character.
Although the link between COVID-19 and ALI has been established, the particularities of the patients remain poorly described and their management not codified because of its emergent character.
This study calculated a more accurate 2020 PAD prevalence employing the Diabetes Method and to compare PAD prevalence by this method with those of the Criqui/PARTNERS and Nehler methods for 1995 and for the 2010 to 2030 period.
This study calculated a more accurate 2020 PAD prevalence employing the Diabetes Method and to compare PAD prevalence by this method with those of the Criqui/PARTNERS and Nehler methods for 1995 and for the 2010 to 2030 period.
One of the many complications of COVID-19 is blood hypercoagulability, which can result in acute limb ischemia (ALI). This study was conducted to present ALI as a complication of hypercoagulability caused by COVID-19 in a hospital in...
One of the many complications of COVID-19 is blood hypercoagulability, which can result in acute limb ischemia (ALI). This study was conducted to present ALI as a complication of hypercoagulability caused by COVID-19 in a hospital in...
The purpose of this long-term retrospective study is to report a tertiary care center experience on the placement of chemoports by interventional radiologists, including technical success rates, complication rates, and clinical outcomes.
The purpose of this long-term retrospective study is to report a tertiary care center experience on the placement of chemoports by interventional radiologists, including technical success rates, complication rates, and clinical outcomes.
The Symplicity Spyral RDN system, approved by the U.S. FDA in November 2023, is an innovative, minimally invasive procedure that delivers radiofrequency energy to nerves near the kidneys that can become overactive and contribute to high blood...
The Symplicity Spyral RDN system, approved by the U.S. FDA in November 2023, is an innovative, minimally invasive procedure that delivers radiofrequency energy to nerves near the kidneys that can become overactive and contribute to high blood...
Peer-reviewed data highlights successful clinical study with 35.5% clot burden reduction, validating the safety, efficacy, and efficiency of AlphaVac F1885 System in pulmonary embolism treatment.
LATHAM, N.Y.--(BUSINESS WIRE)--Jan. 13,...
Peer-reviewed data highlights successful clinical study with 35.5% clot burden reduction, validating the safety, efficacy, and efficiency of AlphaVac F1885 System in pulmonary embolism treatment.
LATHAM, N.Y.--(BUSINESS WIRE)--Jan. 13,...
MENLO PARK, Calif., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Inquis Medical, a leading innovator in venous thromboembolic disease treatment, today announced completion of patient enrollment in its AVENTUS Clinical Trial, a pivotal Investigational...
MENLO PARK, Calif., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Inquis Medical, a leading innovator in venous thromboembolic disease treatment, today announced completion of patient enrollment in its AVENTUS Clinical Trial, a pivotal Investigational...
Eric A. Secemsky, MD, MSc, lead investigator for the ELITE-BTK pivotal trial, said, “R3 Vascular’s novel approach in the design of its next generation bioresorbable drug eluting scaffold is of great interest to the physician community and has...
Eric A. Secemsky, MD, MSc, lead investigator for the ELITE-BTK pivotal trial, said, “R3 Vascular’s novel approach in the design of its next generation bioresorbable drug eluting scaffold is of great interest to the physician community and has...
Clinicians from Germany, Dubai, Japan, U.S., Switzerland among scrub-in and live case transmissions; educational program features 500+ vascular, endovascular presentations.
MALVERN PA., (January 13, 2024) — First-to-podium data...
Clinicians from Germany, Dubai, Japan, U.S., Switzerland among scrub-in and live case transmissions; educational program features 500+ vascular, endovascular presentations.
MALVERN PA., (January 13, 2024) — First-to-podium data...
This agreement includes Contego Medical’s portfolio of commercially available products, including the recently FDA approved Neuroguard IEP® System, a unique 3-in-1 carotid stenting system that combines a high-performance stent, post-dilation...
This agreement includes Contego Medical’s portfolio of commercially available products, including the recently FDA approved Neuroguard IEP® System, a unique 3-in-1 carotid stenting system that combines a high-performance stent, post-dilation...
Data showcased in two late-breaking clinical trial presentations at Paris Vascular Insights Course
PARIS – December 13, 2024 – Sensome, the pioneer of microsensing technology for instant intra-operative tissue analysis, today announced...
Data showcased in two late-breaking clinical trial presentations at Paris Vascular Insights Course
PARIS – December 13, 2024 – Sensome, the pioneer of microsensing technology for instant intra-operative tissue analysis, today announced...
The integration follows the completion of a successful trial of EchoSolv-AS at Beth Israel in September 2024, in which BIDMC researchers validated the technology’s key performance metrics.
The integration follows the completion of a successful trial of EchoSolv-AS at Beth Israel in September 2024, in which BIDMC researchers validated the technology’s key performance metrics.
“With the 200 cm length, the R2P NaviCross catheter provides physicians performing percutaneous transluminal endovascular procedures from the radial artery a valuable tool to enhance their ability to safely and efficiently complete more...
“With the 200 cm length, the R2P NaviCross catheter provides physicians performing percutaneous transluminal endovascular procedures from the radial artery a valuable tool to enhance their ability to safely and efficiently complete more...
Hechingen, November 26th, 2024 -- Shortly after receiving the CE certification for its BeFlared Stent Graft System, the world’s first dedicated bridging stent for fenestrated endovascular aneurysm repair (FEVAR), Bentley announced the...
Hechingen, November 26th, 2024 -- Shortly after receiving the CE certification for its BeFlared Stent Graft System, the world’s first dedicated bridging stent for fenestrated endovascular aneurysm repair (FEVAR), Bentley announced the...
